← FDA DRUG APPROVALS

FDA ANDA · ANDA206738

PIOGLITAZONE HYDROCHLORIDE

Sponsor: PURACAP PHARM LLC

APPLICATION
ANDA206738
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-06
LATEST ACTION
2018-11-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 30MG BASE · TABLET · ORAL
PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 45MG BASE · TABLET · ORAL
PIOGLITAZONE HYDROCHLORIDEPrescription
PIOGLITAZONE HYDROCHLORIDE EQ 15MG BASE · TABLET · ORAL

Approval history

2018-11-29Labeling · Supplement 1 · standardAP
2017-10-06UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →